Search Results 2301-2310 of 21862 for platelets

1. Brain Tumor Program - Clinical trials

   ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection. EF-41/KEYNOTE D58: Phase 3 Study Of Optune Concomitant With Temozolomide ...

2. The ENCIRCLE Trial - Mayo Clinic

   ... platelet < 50,000 cells/mL), history of bleeding diathesis or coagulopathy, or hypercoagulable states; Refusal of blood products. Female who is pregnant or ...

3. A Study of Pembrolizumab and Ruxolitinib Phosphate for Treating Patients with Metastatic Stage IV Triple Negative Breast Cancer - Mayo Clinic

   Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x Upper Limit Normal (ULN);; AST (SGOT) and ALT (SGPT) ≤ 2.5 x ULN or < 5 x ULN if organ involvement ...

4. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   Platelets count ≥ 100 x10^9 /L;; Total bilirubin ≤ 1.5 x ULN (except for patients with Gilbert's syndrome who may be included if total bilirubin ≤ 2.5 x ...

5. Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer that has been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) - Mayo Clinic

   Platelets >= 30,000/mm^3; Hemoglobin >= 8.0 g/dL; Serum creatinine =< 2 x ULN; Prior to randomization patients with any non-hematologic toxicity from surgery ...

6. ORAL AZ-3102 in Patients With GM2 Gangliosidosis or Niemann Pick Type C Disease - Mayo Clinic

   Platelet count < 100 x 10^9 /L. Presence of moderate or severe renal impairment (estimated GFR < 60 mL/min/1.73 m^2 ); Prior participation in a clinical ...

7. Physical Medicine and Rehabilitation - Doctors - Mayo Clinic

   tal injection, Joint examination, Intramuscular injection, Platelet rich plasma injection, Arthritis rehabilitation, Trigger point injection, Soft tissue ...

8. Hematology - Clinical trials

   ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection. Pagination Clinical studies. PrevPrevious Page · Go to page 44 · Go to page 5 ...

9. An Investigational Drug (TPST-1495) In Patients With Familial Adenomatous Polyposis - Mayo Clinic

   * Platelet count ≥ 100 x 10\^9/L * Hemoglobin ≥ 11.5 g/dL * Total bilirubin ≤ 1.5 x institutional upper limit normal (ULN) (unless patient has Gilbert's)

10. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    Adequate hematological function (neutrophils >1 × 109/L, platelet count >100 × 109/L, hemoglobin >9 g/dL) with no prior transfusions within 2 weeks.